4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma

Clinical trial NCT00943449 · COMPLETED

Trial details

NCT number: NCT00943449
Sponsor: 4SC AG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2009-07-01
Primary completion: 2012-06-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.